Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
-process and release testing of GMP Manufacturing and analytical development for cellular immunotherapy products. This is a fast-paced lab involved in cutting edge technology, research and clinical cellular
-
, including first-in-human studies with genetically engineered hematopoietic stem and progenitor cells (HSPC) and T cells. As a successful candidate, you will: · Conduct research on next-generation
-
experience) is available in the Cellular Therapy Production Center (CTPC). This is a fast-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will be
-
experience) is available in the Cellular Therapy Production Center (CTPC). This is a fast-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their
-
Knowledge of collection agency work, probate courts and its requirements, and bankruptcy laws and regulations Advanced written and verbal communication skills Proficient with technology, spreadsheet
-
its requirements, and bankruptcy laws and regulations Advanced written and verbal communication skills Proficient with technology, spreadsheet management skills, with the ability to analyze trends
-
distinguished leader serving as the Director of the Division of Epigenetics and Transcriptional Engineering at City of Hope Cancer Center. His lab investigates epigenetic mechanisms of drug resistance and
-
values and goals, advance care planning, and leveraging technology to enhance the coordination and delivery of patient-centered medical care in serious illness. As a successful candidate, you will